85X0 logo

Bioextrax AB (publ)DB:85X0 Stock Report

Market Cap €11.5m
Share Price
n/a
1Y-14.7%
7D-7.0%
1D-2.1%
Portfolio Value
View

Bioextrax AB (publ)

DB:85X0 Stock Report

Market Cap: €11.5m

Bioextrax (85X0) Stock Overview

Develops and commercializes a bio-based extraction platform technology. More details

85X0 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

85X0 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW495,210 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
495,210 investors already sharing narratives

Bioextrax AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bioextrax
Historical stock prices
Current Share PriceSEK 0.24
52 Week HighSEK 0.35
52 Week LowSEK 0.15
Beta1.58
1 Month Change9.68%
3 Month Change9.17%
1 Year Change-14.70%
3 Year Change-50.72%
5 Year Change-91.14%
Change since IPO-88.83%

Recent News & Updates

Recent updates

Shareholder Returns

85X0DE MachineryDE Market
7D-7.0%-4.5%-2.3%
1Y-14.7%-2.4%0.3%

Return vs Industry: 85X0 underperformed the German Machinery industry which returned -2.1% over the past year.

Return vs Market: 85X0 underperformed the German Market which returned -0.1% over the past year.

Price Volatility

Is 85X0's price volatile compared to industry and market?
85X0 volatility
85X0 Average Weekly Movement9.3%
Machinery Industry Average Movement4.4%
Market Average Movement5.4%
10% most volatile stocks in DE Market12.6%
10% least volatile stocks in DE Market2.8%

Stable Share Price: 85X0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 85X0's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
201414Edvard Hallbioextrax.com

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; and keratin microfibers provides insulation, additive and barrier properties for composites, agriculture, filtration, padding, textiles, and more.

Bioextrax AB (publ) Fundamentals Summary

How do Bioextrax's earnings and revenue compare to its market cap?
85X0 fundamental statistics
Market cap€11.53m
Earnings (TTM)-€1.63m
Revenue (TTM)€119.86k
96.2x
P/S Ratio
-7.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
85X0 income statement (TTM)
RevenueSEK 1.33m
Cost of RevenueSEK 1.16m
Gross ProfitSEK 170.00k
Other ExpensesSEK 18.22m
Earnings-SEK 18.05m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.38
Gross Margin12.82%
Net Profit Margin-1,361.01%
Debt/Equity Ratio0%

How did 85X0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/13 08:27
End of Day Share Price 2026/07/13 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bioextrax AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.